Intersect ENT, Inc. (XENT): Price and Financial Metrics


Intersect ENT, Inc. (XENT): $16.54

-0.05 (-0.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

XENT POWR Grades


  • Growth is the dimension where XENT ranks best; there it ranks ahead of 72.32% of US stocks.
  • The strongest trend for XENT is in Stability, which has been heading up over the past 31 weeks.
  • XENT's current lowest rank is in the Sentiment metric (where it is better than 15.56% of US stocks).

XENT Stock Summary

  • With a year-over-year growth in debt of 679.39%, Intersect ENT Inc's debt growth rate surpasses 97.84% of about US stocks.
  • As for revenue growth, note that XENT's revenue has grown -16.85% over the past 12 months; that beats the revenue growth of just 21.36% of US companies in our set.
  • Intersect ENT Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -12.24%, greater than the shareholder yield of only 18.31% of stocks in our set.
  • Stocks that are quantitatively similar to XENT, based on their financial statements, market capitalization, and price volatility, are EKSO, EPZM, GTYH, QUOT, and TWOU.
  • Visit XENT's SEC page to see the company's official filings. To visit the company's web site, go to www.intersectent.com.

XENT Price Target

For more insight on analysts targets of XENT, see our XENT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.00 Average Broker Recommendation 1.72 (Moderate Buy)

XENT Stock Price Chart Interactive Chart >

Price chart for XENT

XENT Price/Volume Stats

Current price $16.54 52-week high $26.98
Prev. close $16.59 52-week low $11.66
Day low $16.41 Volume 88,000
Day high $17.05 Avg. volume 189,936
50-day MA $19.24 Dividend yield N/A
200-day MA $20.18 Market Cap 548.15M

Intersect ENT, Inc. (XENT) Company Bio


Intersect ENT provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. The company was founded in 2003 and is based in Menlo Park, California.


XENT Latest News Stream


Event/Time News Detail
Loading, please wait...

XENT Latest Social Stream


Loading social stream, please wait...

View Full XENT Social Stream

Latest XENT News From Around the Web

Below are the latest news stories about Intersect ENT Inc that investors may wish to consider to help them evaluate XENT as an investment opportunity.

5 Probable MedTech Winners Post-COVID on Discounted PEG

Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.

Yahoo | June 11, 2021

Why Is Intersect ENT (XENT) Down 10.8% Since Last Earnings Report?

Intersect ENT (XENT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | June 9, 2021

Estimating The Intrinsic Value Of Intersect ENT, Inc. (NASDAQ:XENT)

How far off is Intersect ENT, Inc. ( NASDAQ:XENT ) from its intrinsic value? Using the most recent financial data...

Yahoo | June 8, 2021

Intersect ENT (XENT) Receives CE Mark for PROPEL Contour

The CE Mark approval is backed by positive results from Intersect ENT's (XENT) PROGRESS clinical study of the PROPEL Contour.

Yahoo | May 24, 2021

Intersect ENT receives CE Mark approval for PROPEL Contour sinus implant

Intersect ENT (XENT) has received CE Mark approval for the company’s PROPEL Contour (mometasone furoate) sinus implant enabling sales and distribution in the European Union.PROPEL Contour is specifically designed to maintain patency and reduce inflammation, and conform to the sinus openings.The approval was supported by positive data from the PROPEL Contour...

Seeking Alpha | May 20, 2021

Read More 'XENT' Stories Here

XENT Price Returns

1-mo -6.34%
3-mo -24.89%
6-mo -24.75%
1-year 32.64%
3-year -55.30%
5-year 15.10%
YTD -27.77%
2020 -8.03%
2019 -11.64%
2018 -13.02%
2017 167.77%
2016 -46.22%

Continue Researching XENT

Want to see what other sources are saying about Intersect ENT Inc's financials and stock price? Try the links below:

Intersect ENT Inc (XENT) Stock Price | Nasdaq
Intersect ENT Inc (XENT) Stock Quote, History and News - Yahoo Finance
Intersect ENT Inc (XENT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8734 seconds.